TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 APPLICATION GRID
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTION
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 LARGE NUMBER OF APPROVALS FOR IODINATED AGENTS
3.1.2 RISING AGING POPULATION
3.1.3 INCREASING NUMBER OF CHRONIC DISEASES
3.1.4 INCREASING RESEARCH ACTIVITIES FOR CONTRAST AGENTS
3.2 RESTRAINTS
3.2.1 HIGH COST OF CONTRAST MEDIA
3.2.2 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS
3.3 OPPORTUNITIES
3.3.1 GROWING HEALTHCARE INFRASTRUCTURE
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.3.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
3.3.4 UPCOMING GENERIC CONTRAST MEDIA AGENTS
?
3.4 CHALLENGES
3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT
3.4.2 RESTRICTION AND WITHDRAWAL OF LINEAR GADOLINIUM-BASED CONTRAST AGENTS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION
6.1 OVERVIEW
6.2 INTRAVENOUS
6.3 ORAL
6.4 RECTAL
6.5 OTHERS
7 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL
7.3 SPECIALTY CLINICS
7.3.1 IMAGING CENTERS
7.3.2 PRIVATE PRACTICES
7.4 DIAGNOSTIC CENTERS
7.5 AMBULATORY SURGICAL CENTERS
7.6 RESEARCH & ACADEMIC INSTITUTES
8 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION
8.1 OVERVIEW
8.2 CARDIOLOGY
8.2.1 PERCUTANEOUS CORONARY DISEASE
8.2.2 STRUCTURAL HEART DISEASE
8.2.3 CONGENITAL HEART DISEASE
8.2.4 ELECTROPHYSIOLOGY
8.3 NEUROLOGY
8.4 GENERAL SURGERY
8.5 ONCOLOGY
8.6 UROLOGY
9 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE
9.1 OVERVIEW
9.2 NON-IONIC
9.3 IONIC
10 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY
10.1 ASIA-PACIFIC
10.1.1 CHINA
10.1.2 JAPAN
10.1.3 SOUTH KOREA
10.1.4 INDIA
10.1.5 AUSTRALIA
10.1.6 SINGAPORE
10.1.7 THAILAND
10.1.8 MALAYSIA
10.1.9 INDONESIA
10.1.10 PHILIPPINES
10.1.11 REST OF ASIA-PACIFIC
11 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILES
12.1 BRACCO DIAGNOSTIC INC.
12.1.1 COMPANY SNAPSHOT
12.1.2 COMPANY SHARE ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 RECENT DEVELOPMENT
12.2 GENERAL ELECTRIC
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
?
12.3 GUERBET
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 BAYER AG
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 RECENT DEVELOPMENT
12.5 IMAX
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENT
12.6 ISO-TEX DIAGNOSTICS, INC.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 J.B.CHEMICALS AND PHARMACEUTICALS LTD.
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 NOVALEK PHARMACEUTICALS PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 TAEJOON PHARM
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.10 UNIJULES LIFE SCIENCES LTD.
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS